Back
Stoke Therapeutics Stock Price Chart
Sponsored
STOK
Sponsored
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.
Sell
37
STOK
Stoke Therapeutics
Last Price:
12.03
Seasonality Move:
14.1%
7 Day Trial
ALL ACCESS PASS
$
7
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.48 | Buy |
20-day SMA: | 12.3 | Buy |
50-day SMA: | 13.63 | Sell |
200-day SMA: | 11.47 | Buy |
8-day EMA: | 12.55 | Sell |
20-day EMA: | 12.67 | Sell |
50-day EMA: | 13.25 | Sell |
200-day EMA: | 11.96 | Buy |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 46.33 | Sell |
Chaikin Money Flow: | -80410 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.7 - 13.78) | Sell |
Bollinger Bands (100): | (12.83 - 15.29) | Sell |
Stoke Therapeutics Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 12.52 while STOK 8-day simple moving average is 12.48, which is a Buy signal.
- The stock price of STOK is 12.52 while Stoke Therapeutics 20-day SMA is 12.30, which makes it a Buy.
- Stoke Therapeutics 50-day simple moving average is 13.63 while STOK share price is 12.52, making it a Sell technically.
- STOK stock price is 12.52 and Stoke Therapeutics 200-day simple moving average is 11.47, creating a Buy signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
37
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a Sell
The current Stoke Therapeutics [STOK] share price is $12.52. The Score for STOK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
659.15M
Price in USD:
12.52
Share Volume:
211.45K
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
3.35
Sell
37
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?
The Stoke Therapeutics stock price is 12.52 USD today. -
Will STOK stock go up or go down?
Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Stoke Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 12.52 while STOK 8-day exponential moving average is 12.55, which is a Sell signal.
- The stock price of STOK is 12.52 while Stoke Therapeutics 20-day EMA is 12.67, which makes it a Sell.
- Stoke Therapeutics 50-day exponential moving average is 13.25 while STOK share price is 12.52, making it a Sell technically.
- STOK stock price is 12.52 and Stoke Therapeutics 200-day simple moving average is 11.96, creating a Buy signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
- STOK Moving Average Covergence Divergence (MACD) indicator is -0.3, suggesting Stoke Therapeutics is a Sell
- Stoke Therapeutics Relative Strength Index (RSI) is 46.33, which suggest Stoke Therapeutics is oversold
- The Bollinger Bands (25) for Stoke Therapeutics is (11.7 - 13.78), which suggest Stoke Therapeutics is a Sell
- The Bollinger Bands (100) for Stoke Therapeutics is (12.83 - 15.29), which suggest Stoke Therapeutics is a Sell
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.